In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Targeted Genetics receives $4.8 Million in equity funding from Biogen
Targeted Genetics completes acquisition of Genovo
Sirna Therapeutics and Targeted Genetics Form Huntington's Disease Collaboration
Crucell signs license pact with Targeted Genetics
Targeted Genetics and CFFT to develop treatment for CF
TARGETED GENETICS ANNOUNCES CONCLUSION OF JOINT VENTURE RELATIONSHIP WITH ELAN
Targeted Genetics signs licensing agreement